Blood-borne viral infections, including the hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis Delta virus (HDV), and the human immunodeficiency virus (HIV), are highly prevalent in low and middle-income countries (LMICs) and represent a significant public health threat. The evolutionary history and transmission dynamics of these pathogens are imprinted on their genomes. Scientists need to understand how these pathogens evolve to develop successful strategies for drug and vaccine and control the spread of these infections or co-infections.
The objective of this topic is to bring in new data that could enrich the available literature on the burden, diagnosis, viral genetic diversity, treatment and prevention of these viral infections in LMICs. Molecular epidemiology studies, innovative solutions applying genetics and viral genomics are of particular interest. Integration of sociocultural aspects, drug and vaccine discovery efforts, diagnostic development, and impact of prevention measures are also of interest.
This Research Topic will accept submissions of Original Research, Brief Research Reports, Clinical Trials, General Commentaries, Hypothesis & Theory, Methods, Mini Reviews, Systematic Reviews, Opinion, Perspectives, and Policy briefs. Specific topics to be addressed include, but are not limited to :
- Surveillance of blood-borne viral infections in under-surveilled settings
- Genomics-based development of diagnostic tools, antiviral drugs and vaccines
- New approaches for prevention and control of blood-borne viral infectious diseases
- Antiviral resistance mechanisms and transmission
- Evolutionary and spatio-temporal dynamics of viruses circulating across populations in LMICs
- Behavioral changes and evidence-based decisions to manage blood-borne viral diseases
- Evolutionary history of these viruses and how they have adapted to different populations and geographic regions
Keywords:
Blood-borne infections, LMICs, viral evolution, transmission dynamics, resistance, disease progression, antiviral therapy.
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Blood-borne viral infections, including the hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis Delta virus (HDV), and the human immunodeficiency virus (HIV), are highly prevalent in low and middle-income countries (LMICs) and represent a significant public health threat. The evolutionary history and transmission dynamics of these pathogens are imprinted on their genomes. Scientists need to understand how these pathogens evolve to develop successful strategies for drug and vaccine and control the spread of these infections or co-infections.
The objective of this topic is to bring in new data that could enrich the available literature on the burden, diagnosis, viral genetic diversity, treatment and prevention of these viral infections in LMICs. Molecular epidemiology studies, innovative solutions applying genetics and viral genomics are of particular interest. Integration of sociocultural aspects, drug and vaccine discovery efforts, diagnostic development, and impact of prevention measures are also of interest.
This Research Topic will accept submissions of Original Research, Brief Research Reports, Clinical Trials, General Commentaries, Hypothesis & Theory, Methods, Mini Reviews, Systematic Reviews, Opinion, Perspectives, and Policy briefs. Specific topics to be addressed include, but are not limited to :
- Surveillance of blood-borne viral infections in under-surveilled settings
- Genomics-based development of diagnostic tools, antiviral drugs and vaccines
- New approaches for prevention and control of blood-borne viral infectious diseases
- Antiviral resistance mechanisms and transmission
- Evolutionary and spatio-temporal dynamics of viruses circulating across populations in LMICs
- Behavioral changes and evidence-based decisions to manage blood-borne viral diseases
- Evolutionary history of these viruses and how they have adapted to different populations and geographic regions
Keywords:
Blood-borne infections, LMICs, viral evolution, transmission dynamics, resistance, disease progression, antiviral therapy.
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.